These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37764933)

  • 21. Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial.
    Paterson DL; Bassetti M; Motyl M; Johnson MG; Castanheira M; Jensen EH; Huntington JA; Yu B; Wolf DJ; Bruno CJ
    J Antimicrob Chemother; 2022 Aug; 77(9):2522-2531. PubMed ID: 35781341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of carbapenem-resistant
    Rizi KS; Aryan E; Youssefi M; Ghazvini K; Meshkat Z; Amini Y; Safdari H; Derakhshan M; Farsiani H
    Future Microbiol; 2023 Mar; 18():215-223. PubMed ID: 37129534
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of ampC derepression on cefepime MIC in Enterobacterales with chromosomally encoded inducible AmpC β-lactamase.
    Kohlmann R; Bähr T; Gatermann SG
    Clin Microbiol Infect; 2019 Sep; 25(9):1158.e1-1158.e4. PubMed ID: 31128286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Rapid Immunochromatographic Tests for the Direct Detection of Extended Spectrum Beta-Lactamases and Carbapenemases in Enterobacterales Isolated from Positive Blood Cultures.
    Keshta AS; Elamin N; Hasan MR; Pérez-López A; Roscoe D; Tang P; Suleiman M
    Microbiol Spectr; 2021 Dec; 9(3):e0078521. PubMed ID: 34878297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and Risk Factors of Death in Patients with AmpC
    Silva ASDN; da Silva NCZ; do Valle FM; da Rocha JA; Ehrlich S; Martins IS
    Infect Drug Resist; 2024; 17():4023-4035. PubMed ID: 39309068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of β-lactamases and emergence of carbapenemases co-occurring Enterobacterales isolates with high-level antibiotic resistance identified from patients with intra-abdominal infection in the Asia-Pacific region, 2015-2018.
    Chen YC; Chen WY; Hsu WY; Tang HJ; Chou Y; Chang YH; Chen CC; Chuang YC; Chang TH
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1263-1272. PubMed ID: 34330663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing
    da Cunha Ferreira T; Martins IS
    Infect Drug Resist; 2021; 14():3083-3097. PubMed ID: 34408452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales.
    Hardy ME; Kenney RM; Tibbetts RJ; Shallal AB; Veve MP
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0082623. PubMed ID: 37882541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility and distribution of extended-spectrum β-lactamases, AmpC β-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008-2011.
    Yang JH; Sheng WH; Hsueh PR;
    J Glob Antimicrob Resist; 2020 Sep; 22():398-407. PubMed ID: 32311502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High burden and diversity of carbapenemase-producing Enterobacterales observed in wastewater of a tertiary care hospital in Germany.
    Carlsen L; Büttner H; Christner M; Franke G; Indenbirken D; Knobling B; Lütgehetmann M; Knobloch J
    Int J Hyg Environ Health; 2022 May; 242():113968. PubMed ID: 35390565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
    Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS
    Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of extended-spectrum β-lactamases in
    Chao CM; Lai CC; Yu WL
    Front Microbiol; 2022; 13():1060050. PubMed ID: 36762100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART).
    Sheng WH; Badal RE; Hsueh PR;
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2981-8. PubMed ID: 23587958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.
    Beshah D; Desta AF; Woldemichael GB; Belachew EB; Derese SG; Zelelie TZ; Desalegn Z; Tessema TS; Gebreselasie S; Abebe T
    PLoS One; 2023; 18(6):e0287453. PubMed ID: 37368908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019.
    Rossolini GM; Stone G; Kantecki M; Arhin FF
    J Glob Antimicrob Resist; 2022 Sep; 30():214-221. PubMed ID: 35760303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments.
    Boattini M; Bianco G; Iannaccone M; Ghibaudo D; Almeida A; Cavallo R; Costa C
    Eur J Clin Microbiol Infect Dis; 2021 Jul; 40(7):1495-1501. PubMed ID: 33598829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
    She D; Liu Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.